Literature DB >> 32248428

Systemic Adverse Events Associated with Compounded Topical Pain Products.

Jenny Kim1, Karen Konkel2, S Christopher Jones2, Lynda McCulley2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32248428      PMCID： PMC7574883          DOI： 10.1007/s40264-020-00927-2

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  7 in total

1.  Dermal exposure to a compounded pain cream resulting in severely elevated clonidine concentration.

Authors:  Adam C Pomerleau; Casey E Gooden; Corinne R Fantz; Brent W Morgan
Journal:  J Med Toxicol       Date:  2014-03

2.  Staying Topical: An Unusual Case of Serotonin Syndrome.

Authors:  Ciani Ellison; Stanley Lyndon
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153

3.  Safety of Topical Neuromodulators for the Treatment of Pruritus.

Authors:  Michael A Cardis; Helena B Pasieka
Journal:  JAMA Dermatol       Date:  2016-12-01       Impact factor: 10.282

4.  Delirium Following Topical Application of Compounded Creams Containing Multiple Analgesic Medications in Geriatric Patients: Two New Cases.

Authors:  Alyssa A Soumoff; David L Cook; Caroline C Clark
Journal:  Psychosomatics       Date:  2017-08-12       Impact factor: 2.386

5.  Toward Better-Quality Compounded Drugs - An Update from the FDA.

Authors:  Janet Woodcock; Julie Dohm
Journal:  N Engl J Med       Date:  2017-12-28       Impact factor: 91.245

6.  Clonidine Overdose in a Toddler Due to Accidental Ingestion of a Compounding Cream.

Authors:  Alexis L Cates; Scott M Wheatley; Kenneth D Katz
Journal:  Pediatr Emerg Care       Date:  2018-04       Impact factor: 1.454

7.  Compounded ointment results in severe toxicity in a pediatric patient.

Authors:  Ross W Sullivan; Matthew Ryzewski; Michael G Holland; Jeanna M Marraffa
Journal:  Pediatr Emerg Care       Date:  2013-11       Impact factor: 1.454
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.